造影剤および放射性医薬品の米国市場：2008年

Abstract

The US market for contrast agents and radiopharmaceuticals was valued at over $3.5 billion in 2007.

This market is comprised of five different markets-radiopharmaceuticals, computed tomography (CT) and X-ray contrast agents, magnetic resonance imaging (MRI) contrast agents, ultrasound contrast agents, and power injectors.

Table of Contents

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 US CONTRAST AGENT AND RADIOPHARMACEUTICAL MARKET

• 1.1 Market Overview
• 1.2 Market Analysis
  • 1.2.1 Market Definition
  • 1.2.2 Procedures
    • 1.2.2.1 Radiopharmaceutical Procedures
    • 1.2.2.2 CT and X-Ray Contrast-Enhanced Procedures
    • 1.2.2.3 Contrast-Enhanced MRI Procedures
  • 1.2.3 Market Forecast
    • 1.2.3.1 Radiopharmaceutical Market
    • 1.2.3.2 CT and X-Ray Contrast Agent Market
    • 1.2.3.3 MRI Contrast Agent Market
    • 1.2.3.4 Ultrasound Contrast Agent Market
    • 1.2.3.5 Power Injector Market
  • 1.2.4 Market Drivers and Limiters
    • 1.2.4.1 Market Drivers
    • 1.2.4.2 Market Limiters
• 1.3 Competitive Analysis

2.0 RADIOPHARMACEUTICAL MARKET

• 2.1 Market Overview
• 2.2 Market Analysis
  • 2.2.1 Market Definition
  • 2.2.2 Procedures
  • 2.2.3 Market Forecast
    • 2.2.3.1 SPECT Radiopharmaceutical Market
    • 2.2.3.2 PET Radiopharmaceutical Market
    • 2.2.3.3 Installed Base
  • 2.2.4 Market Drivers and Limiters
    • 2.2.4.1 Market Drivers
    • 2.2.4.2 Market Limiters
• 2.3 Competitive Analysis

3.0 CT AND X-RAY CONTRAST AGENT MARKET

• 3.1 Market Overview
• 3.2 Market Analysis
  • 3.2.1 Market Definition
  • 3.2.2 Procedures
  • 3.2.3 Market Forecast
    • 3.2.3.1 CT Contrast Agent Market
    • 3.2.3.2 Cardiovascular X-Ray Contrast Agent Market
    • 3.2.3.3 Conventional X-Ray Contrast Agent Market
    • 3.2.3.4 CT Installed Base
    • 3.2.3.5 Fixed Cardiovascular C-Arm Systems Installed Base
  • 3.2.4 Market Drivers and Limiters
    • 3.2.4.1 Market Drivers
    • 3.2.4.2 Market Limiters
• 3.3 Competitive Analysis

4.0 MRI CONTRAST AGENT MARKET

• 4.1 Market Overview
• 4.2 Market Analysis
  • 4.2.1 Market Definition
  • 4.2.2 Procedures
  • 4.2.3 Market Forecast
    • 4.2.3.1 Hospital MRI Contrast Agent Market
    • 4.2.3.2 Nonhospital MRI Contrast Agent Market
    • 4.2.3.3 Installed Base
• 4.2.4 Market Drivers and Limiters
  • 4.2.4.1 Market Drivers
  • 4.2.4.2 Market Limiters
• 4.3 Competitive Analysis

5.0 ULTRASOUND CONTRAST AGENT MARKET

• 5.1 Market Overview
• 5.2 Market Analysis
  • 5.2.1 Market Definition
  • 5.2.2 Procedures
  • 5.2.3 Market Forecast
    • 5.2.3.1 Installed Base
  • 5.2.4 Market Drivers and Limiters
    • 5.2.4.1 Market Drivers
    • 5.2.4.2 Market Limiters
• 5.3 Competitive Analysis
  • 5.3.1 Emerging Competitors

6.0 POWER INJECTOR MARKET

• 6.1 Market Overview
• 6.2 Market Analysis
  • 6.2.1 Market Definition
  • 6.2.2 Procedures
  • 6.2.3 Market Forecast
    • 6.2.3.1 CT Power Injector Market
    • 6.2.3.2 MRI Power Injector Market
    • 6.2.3.3 Installed Base
  • 6.2.4 Market Drivers and Limiters
    • 6.2.4.1 Market Drivers
    • 6.2.4.2 Market Limiters
• 6.3 Competitive Analysis

APPENDIX A: MRG ACRONYMS AND INITIALISMS

List of Exhibits

EXECUTIVE SUMMARY

• Exhibit 1: Contrast Agents and Radiopharmaceutical Market, by Segment, US (US$), 2006-2012
• Exhibit 2: Radiopharmaceutical Market, by Segment, US (US$), 2006-2012
• Exhibit 3: CT and X-Ray Contrast Agent Market, by Segment, US (US$), 2006-2012
• Exhibit 4: MRI Contrast Agent Market, US (US$), 2006-2012
• Exhibit 5: Ultrasound Contrast Agent Market, US (US$), 2006-2012
• Exhibit 6: Power Injector Market, by Segment, US (US$), 2006-2012
• Exhibit 7: Leading Competitors in the Contrast Agent and Radiopharmaceutical Market, US, 2007

METHODOLOGY

CHAPTER 1: US CONTRAST AGENT AND RADIOPHARMACEUTICAL MARKET

• Exhibit 8: Contrast Agent and Radiopharmaceutical Market, US (US$), 2006-2012
• Exhibit 9: Radiopharmaceutical Procedures, by Segment US, 2006-2012 (Graphical Format)
• Exhibit 10: Radiopharmaceutical Procedures, by Segment US, 2006-2012 (Tabular Format)
• Exhibit 11: Contrast-Enhanced CT and X-Ray Procedures, by Segment, US, 2006-2012 (Graphical Format)
• Exhibit 12: Contrast-Enhanced CT and X-Ray Procedures, by Segment, US, 2006-2012 (Tabular Format)
• Exhibit 13: Contrast-Enhanced MRI Procedures, by Segment, US, 2006-2012 (Graphical Format)
• Exhibit 14: Contrast-Enhanced MRI Procedures, by Segment, US, 2006-2012 (Tabular Format)
• Exhibit 15: Contrast Agent and Radiopharmaceutical Market, by Segment, US (US$), 2006-2012 (Graphical Format)
• Exhibit 16: Contrast Agent and Radiopharmaceutical Market, by Segment, US (US$), 2006-2012 (Tabular Format)
• Exhibit 17: Contrast Agent and Radiopharmaceutical Market Growth, by Segment, US, 2007-2012
• Exhibit 18: Drivers and Limiters of the Contrast Agent and Radiopharmaceutical Market, US
• Exhibit 19: Leading Competitors in Contrast Agent and Radiopharmaceutical Market, as a % of Total, US, 2007

CHAPTER 2: RADIOPHARMACEUTICAL MARKET

• Exhibit 20: Radiopharmaceutical Market, US (US$), 2006-2012
• Exhibit 21: Radiopharmaceutical Procedures, by Segment, US, 2006-2012 (Graphical Format)
• Exhibit 22: Radiopharmaceutical Procedures, by Segment, US, 2006-2012 (Tabular Format)
• Exhibit 23: SPECT Procedures, US, 2006-2012 (Graphical Format)
• Exhibit 24: PET Procedures, US, 2006-2012 (Graphical Format)
• Exhibit 25: Radiopharmaceutical Market, by Segment, US (US$), 2006-2012 (Graphical Format)
• Exhibit 26: Radiopharmaceutical Market, by Segment, US (US$), 2006-2012 (Tabular Format)
• Exhibit 27: SPECT Radiopharmaceutical Market, US (US$), 2006-2012 (Graphical Format)
• Exhibit 28: SPECT Radiopharmaceutical Market, US (US$), 2006-2012 (Tabular Format)
• Exhibit 29: PET Radiopharmaceutical Market, US (US$), 2006-2012 (Graphical Format)
• Exhibit 30: PET Radiopharmaceutical Market, US (US$), 2006-2012 (Tabular Format)
• Exhibit 31: Nuclear Medicine System Installed Base, US, 2006-2012 (Graphical Format)
• Exhibit 32: Nuclear Medicine Systems Installed Base, US, 2006-2012 (Tabular Format)
• Exhibit 33: Drivers and Limiters of the Radiopharmaceutical Market, US
• Exhibit 34: Leading Competitors in Radiopharmaceutical Market, as a % of Total, US, 2007 (Graphical Format)
• Exhibit 35: Leading Competitors in Radiopharmaceutical Market, by Segment, as a % of Total, US, 2007 (Tabular Format)
• Exhibit 36: Leading Competitors in SPECT Radiopharmaceutical Market, as a % of Total, US, 2007 (Graphical Format)
• Exhibit 37: Leading Competitors in PET Radiopharmaceutical Market, as a % of Total, US, 2007 (Graphical Format)

CHAPTER 3: CT AND X-RAY CONTRAST AGENT MARKET

• Exhibit 38: CT and X-Ray Contrast Agent Market, US (US$), 2006-2012
• Exhibit 39: Contrast-Enhanced CT and X-Ray Procedures, by Segment, US, 2006-2012 (Graphical Format)
• Exhibit 40: Contrast-Enhanced CT and X-Ray Procedures, by Segment, US, 2006-2012 (Tabular Format)
• Exhibit 41: CT and X-ray Contrast Agent Market, by Segment, US (US$), 2006-2012 (Graphical Format)
• Exhibit 42: CT and X-ray Contrast Agent Market, by Segment, US (US$), 2006-2012 (Tabular Format)
• Exhibit 43: CT Contrast Agent Market, US (US$), 2006-2012 (Graphical Format)
• Exhibit 44: CT Contrast Agent Market, US (US$), 2006-2012 (Tabular Format)
• Exhibit 45: Cardiovascular X-Ray Contrast Agent Market, US (US$), 2006-2012 (Graphical Format)
• Exhibit 46: Cardiovascular X-ray Contrast Agent Market, US (US$), 2006-2012 (Tabular Format)
• Exhibit 47: Conventional X-Ray Contrast Agent Market, US (US$), 2006-2012 (Graphical Format)
• Exhibit 48: Conventional X-Ray Contrast Agent Market, US (US$), 2006-2012 (Tabular Format)
• Exhibit 49: CT System Installed Base, US, 2006-2012 (Graphical Format)
• Exhibit 50: CT System Installed Base, US, 2006-2012 (Tabular Format)
• Exhibit 51: Fixed Cardiovascular C-Arm Installed Base, US, 2006-2012 (Graphical Format)
• Exhibit 52: Fixed C-Arm Installed Base, US, 2006-2012
• Exhibit 53: Drivers and Limiters of the CT and X-Ray Contrast Agent Market, US
• Exhibit 54: Leading Competitors in the CT and X-ray Contrast Agent Market, as a % of Total, US, 2007 (Graphical Format)
• Exhibit 55: Leading Competitors in the CT and X-Ray Contrast Agent Market, as a % of Total, US, 2007 (Tabular Format)

CHAPTER 4: MRI CONTRAST AGENT MARKET

• Exhibit 56: MRI Contrast Agent Market, US (US$), 2006-2012
• Exhibit 57: MRI Contrast-Enhanced Procedures, by Segment, US, 2006-2012 (Graphical Format)
• Exhibit 58: MRI Contrast-Enhanced Procedures, by Segment US, 2006-2012 (Tabular Format)
• Exhibit 59: MRI Contrast Agent Market, by Segment, US (US$), 2006-2012 (Graphical Format)
• Exhibit 60: MRI Contrast Agent Market, by Segment, US (US$), 2006-2012 (Tabular Format)
• Exhibit 61: Hospital MRI Contrast Agent Market, US (US$), 2006-2012 (Graphical Format)
• Exhibit 62: Hospital MRI Contrast Agent Market, US (US$), 2006-2012 (Tabular Format)
• Exhibit 63: Nonhospital MRI Contrast Agent Market, US (US$), 2006-2012 (Graphical Format)
• Exhibit 64: Nonhospital MRI Contrast Agent Market, US (US$), 2006-2012 (Tabular Format)
• Exhibit 65: MRI System Installed Base, US, 2006-2012 (Graphical Format)
• Exhibit 66: MRI System Installed Base, US, 2006-2012 (Tabular Format)
• Exhibit 67: Drivers and Limiters of the MRI Contrast Agent Market, US
• Exhibit 68: Leading Competitors in MRI Contrast Agent Market, as a % of Total, US, 2007 (Graphical Format)
• Exhibit 69: Leading Competitors in MRI Contrast Agent Market, as a % of Total, US, 2007 (Tabular Format)

CHAPTER 5: ULTRASOUND CONTRAST AGENT MARKET

• Exhibit 70: Ultrasound Contrast Agent Market, US (US$), 2006-2012
• Exhibit 71: Ultrasound Contrast Agent Market, US (US$), 2006-2012 (Graphical Format)
• Exhibit 72: Ultrasound Contrast Agent Market, US (US$), 2006-2012 (Tabular Format)
• Exhibit 73: Ultrasound System Installed Base, US, 2006-2012 (Graphical Format)
• Exhibit 74: Ultrasound System Installed Base, US, 2006-2012 (Tabular Format)
• Exhibit 75: Drivers and Limiters of the Ultrasound Contrast Agent Market, US
• Exhibit 76: Leading Competitors in Ultrasound Contrast Agent Market as a % of Total, US, 2007 (Graphical Format)

CHAPTER 6: POWER INJECTOR MARKET

• Exhibit 77: Power Injector Market, US (US$), 2006-2012
• Exhibit 78: Contrast-Enhanced CT Procedures, US, 2006-2012 (Graphical Format)
• Exhibit 79: Contrast-Enhanced CT Procedures, US, 2006-2012 (Tabular Format)
• Exhibit 80: Contrast-Enhanced MRI Procedures, US, 2006-2012 (Graphical Format)
• Exhibit 81: Contrast-Enhanced MRI Procedures, US, 2006-2012 (Tabular Format)
• Exhibit 82: Power Injector Market, by Segment, US (US$), 2006-2012 (Graphical Format)
• Exhibit 83: Power Injector Market, by Segment, US (US$), 2006-2012 (Tabular Format)
• Exhibit 84: CT Power Injector Market, US (US$), 2006-2012 (Graphical Format)
• Exhibit 85: CT Power Injector Market, US (US$), 2006-2012 (Tabular Format)
• Exhibit 86: MRI Power Injector Market, US (US$), 2006-2012 (Graphical Format)
• Exhibit 87: MRI Power Injector Market, US (US$), 2006-2012 (Tabular Format)
• Exhibit 88: Power Injector Installed Base, by Segment, US, 2006-2012 (Graphical Format)
• Exhibit 89: Power Injector Installed Base, by Segment US, 2006-2012 (Tabular Format)
• Exhibit 90: Drivers and Limiters of the Power Injector Market, US
• Exhibit 91: Leading Competitors in Power Injector Market, as a % of Total, US, 2007
• Exhibit 92: Leading Competitors in Power Injector Market, by Segment, as a % of Total, US, 2007
• Exhibit 93: Leading Competitors in CT Power Injector Market, as a % of Total, US, 2007
• Exhibit 94: Leading Competitors in MRI Power Injector Market, as a % of Total, US, 2007